Cresco Labs Inc.
CRLBF
$0.80
-$0.02-2.28%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 173.34M | 151.33M | 161.55M | 164.91M | 163.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 173.34M | 151.33M | 161.55M | 164.91M | 163.62M |
| Cost of Revenue | 86.39M | 75.88M | 78.23M | 85.55M | 80.37M |
| Gross Profit | 86.95M | 75.45M | 83.32M | 79.36M | 83.26M |
| SG&A Expenses | 66.63M | 59.36M | 60.43M | 53.53M | 53.43M |
| Depreciation & Amortization | 6.96M | 4.92M | 4.97M | 5.64M | 4.42M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 159.98M | 140.15M | 143.63M | 144.72M | 138.22M |
| Operating Income | 13.36M | 11.17M | 17.93M | 20.19M | 25.41M |
| Income Before Tax | -3.60M | -2.79M | -87.15M | -10.10M | 2.74M |
| Income Tax Expenses | -18.97M | 14.22M | 1.80M | 11.87M | 16.64M |
| Earnings from Continuing Operations | 15.37M | -17.01M | -88.95M | -21.97M | -13.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.43M | 3.94M | 1.36M | 4.91M | -2.44M |
| Net Income | 16.80M | -13.07M | -87.59M | -17.05M | -16.33M |
| EBIT | 13.36M | 11.17M | 17.93M | 20.19M | 25.41M |
| EBITDA | 26.02M | 23.39M | 28.68M | 33.05M | 37.60M |
| EPS Basic | 0.05 | -0.04 | -0.24 | -0.05 | -0.05 |
| Normalized Basic EPS | 0.00 | 0.01 | 0.02 | 0.03 | 0.02 |
| EPS Diluted | 0.04 | -0.04 | -0.24 | -0.05 | -0.05 |
| Normalized Diluted EPS | 0.00 | 0.01 | 0.02 | 0.03 | 0.02 |
| Average Basic Shares Outstanding | 370.81M | 364.23M | 359.89M | 355.54M | 354.29M |
| Average Diluted Shares Outstanding | 472.32M | 364.23M | 359.89M | 355.54M | 354.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |